MAPT and Alzheimer disease: Current cerebrospinal fluid (CSF), plasma, and blood biomarkers used in AD diagnosis are β‐amyloid species, phospho‐tau and tau, phospho‐tau ratio, neurofilaments, synaptic proteins, activated astrocytes, and inflammatory markers [83, 84, 85, 86, 87, 88, 89, 90].